Literature DB >> 21982523

Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant.

Jonathan S Rink1, Xiaojuan Chen, Xiaomin Zhang, Dixon B Kaufman.   

Abstract

BACKGROUND: Islets are susceptible to damage by proinflammatory cytokines via activation of transcription factor NF-κB. We hypothesized that inhibition of NF-κB activity will decrease cytokine-mediated β-cell injury and improve islet transplant functional outcome.
METHODS: We created a transgenic mouse expressing a degradation resistant N-terminally deleted IκBα (ΔNIκBα) under the control of a commercially available tetracycline-controlled transcriptional activation system using a rat insulin promoter. Isolated islets from transgenic and control mouse strains were exposed to cytokines in vitro and assayed or transplanted.
RESULTS: Western blot analysis showed that ΔNIκBα was significantly increased with doxycycline treatment. Cytokine-induced NF-κB activation was significantly decreased in transgenic (0.065 ± 0.013 absorbance value/μg protein) vs control islets (0.128 ± 0.006; P < .05). Suppression of cytokine-mediated NF-κB activity decreased expression of inducible nitric oxide synthase, monocyte chemoattractant protein-1, and interferon-γ inducible protein-10 RNA transcripts, and significantly decreased nitric oxide production in transgenic islets (0.084 ± 0.043 μM/μg protein) vs. controls (0.594 ± 0.174; P < .01). The insulin stimulation index in islets exposed to cytokines was higher in transgenic vs controls (1.500 ± 0.106 vs 0.800 ± 0.098; P < .01). Syngeneic transplants of a marginal mass of intraportally infused transgenic islets resulted in a reversion to euglycemia in 69.2% of diabetic recipients at a mean of 7.8 ± 1.1 days vs. 35.7% of control islet recipients reverting at a mean of 15.8 ± 2.9 days (P < .05).
CONCLUSION: Conditional and specific suppression of NF-κB activity in β cells protected islets from cytokine-induced dysfunction in vitro and in vivo. These results provide a proof of principle that inhibition of NF-κB activity in donor islets enhances function and improves the outcome of islet transplantation.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982523      PMCID: PMC3256254          DOI: 10.1016/j.surg.2011.07.011

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  42 in total

1.  Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice.

Authors:  M Tanaka; M E Fuentes; K Yamaguchi; M H Durnin; S A Dalrymple; K L Hardy; D V Goeddel
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

2.  Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion.

Authors:  Stefan Norlin; Ulf Ahlgren; Helena Edlund
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

3.  High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation.

Authors:  I Lavon; I Goldberg; S Amit; L Landsman; S Jung; B Z Tsuberi; I Barshack; J Kopolovic; E Galun; H Bujard; Y Ben-Neriah
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells.

Authors:  C A Delaney; D Pavlovic; A Hoorens; D G Pipeleers; D L Eizirik
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

5.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors:  A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 6.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch; W L Suarez-Pinzon
Journal:  Biochem Pharmacol       Date:  1998-04-15       Impact factor: 5.858

Review 7.  Interleukin-15 and its role in chronic inflammatory diseases.

Authors:  I Kirman; B Vainer; O H Nielsen
Journal:  Inflamm Res       Date:  1998-07       Impact factor: 4.575

8.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

9.  Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation.

Authors:  M A Tepper; S G Nadler; J M Esselstyn; K G Sterbenz
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

10.  Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis.

Authors:  D D Taub; T J Sayers; C R Carter; J R Ortaldo
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

View more
  15 in total

Review 1.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

2.  Reg3α Overexpression Protects Pancreatic β Cells from Cytokine-Induced Damage and Improves Islet Transplant Outcome.

Authors:  Ying Ding; Yuemei Xu; Xuanyu Shuai; Xuhui Shi; Xiang Chen; Wenbin Huang; Yun Liu; Xiubin Liang; Zhihong Zhang; Dongming Su
Journal:  Mol Med       Date:  2015-02-05       Impact factor: 6.354

3.  Metformin, beta-cell development, and novel processes following beta-cell ablation in zebrafish.

Authors:  Georgia Wyett; Yann Gibert; Megan Ellis; Hozana A Castillo; Kathryn Aston-Mourney
Journal:  Endocrine       Date:  2017-12-22       Impact factor: 3.633

4.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

5.  Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation.

Authors:  J A SoRelle; T Itoh; H Peng; M A Kanak; K Sugimoto; S Matsumoto; M F Levy; M C Lawrence; B Naziruddin
Journal:  Diabetologia       Date:  2013-01-15       Impact factor: 10.122

6.  IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB.

Authors:  Susan J Burke; Krisztian Stadler; Danhong Lu; Evanna Gleason; Anna Han; Dallas R Donohoe; Richard C Rogers; Gerlinda E Hermann; Michael D Karlstad; J Jason Collier
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-25       Impact factor: 4.310

Review 7.  Anti-inflammatory strategies to enhance islet engraftment and survival.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

8.  Otubain 2 is a novel promoter of beta cell survival as revealed by siRNA high-throughput screens of human pancreatic islets.

Authors:  A Beck; Y Vinik; H Shatz-Azoulay; R Isaac; S Streim; G Jona; S Boura-Halfon; Y Zick
Journal:  Diabetologia       Date:  2013-03-21       Impact factor: 10.122

9.  Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival.

Authors:  Jonathan S Rink; Kaylin M McMahon; Xiaomin Zhang; Xiaojuan Chen; Chad A Mirkin; C Shad Thaxton; Dixon B Kaufman
Journal:  Transplantation       Date:  2013-11-27       Impact factor: 4.939

10.  Inhibition of nuclear factor-κB activation in pancreatic β-cells has a protective effect on allogeneic pancreatic islet graft survival.

Authors:  Roy Eldor; Roy Abel; Dror Sever; Gad Sadoun; Amnon Peled; Ronit Sionov; Danielle Melloul
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.